Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects

AIMS: The aim of this study was to assess the tolerability, pharmacokinetics and inhibitory effect on erythrocyte soluble catechol-O-methyltransferase (S-COMT) activity following repeated doses of opicapone. METHODS: This randomized, placebo-controlled, double-blind study enrolled healthy male subje...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Rocha, José Francisco, Almeida, Luis, Falcão, Amílcar, Palma, P Nuno, Loureiro, Ana I, Pinto, Roberto, Bonifácio, Maria João, Wright, Lyndon C, Nunes, Teresa, Soares-da-Silva, Patrício
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2013
Teme:
Pharmacokinetic Dynamic Relationships
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853535/
https://ncbi.nlm.nih.gov/pubmed/23336248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12081
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items